December 1, 2025

HealthEquity (HQY) Stock Analysis: Exploring a Promising 14.41% Upside in the Burgeoning Healthcare Sector

HealthEquity, Inc. (NASDAQ: HQY) stands prominently in the healthcare sector, specializing in health information services. The company provides a range of technology-enabled platforms that facilitate health..

Legend Biotech Corporation (LEGN) Stock Analysis: Unlocking a 170% Potential Upside with Cutting-Edge CAR-T Therapies

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, is drawing significant attention from investors with its potential for a remarkable 170% upside...

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating a Robust Growth Trajectory in Healthcare

Medpace Holdings, Inc. (NASDAQ: MEDP), a stalwart in the healthcare sector, specifically within the diagnostics and research industry, is marking its presence on the stock market..

Globus Medical, Inc. (GMED) Stock Analysis: Riding the Wave of 22.9% Revenue Growth in the Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specializes in cutting-edge medical devices targeting musculoskeletal disorders. With a market capitalization of $12.3..

Roivant Sciences Ltd. (ROIV) Stock Report: Analyzing a 17.95% Potential Upside for Biotech Investors

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, has drawn significant attention from investors eyeing the healthcare industry. Based in London, this..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth in the Global Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically in the drug manufacturing industry, is making strides in the global animal..

Insmed Incorporated (INSM) Stock Analysis: Exploring Growth Potential in Biotechnology with a 52.4% Revenue Surge

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is drawing significant attention from investors, fueled by its robust revenue growth and promising drug..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Giant with an 8% Upside Potential

IQVIA Holdings, Inc. (IQV), a prominent player in the healthcare sector, operates within the diagnostics and research industry, boasting a market capitalization of $39.17 billion. With..

McKesson Corporation (MCK) Stock Analysis: Navigating Opportunities in Healthcare with a 6.09% Potential Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a key player in the medical distribution industry with a robust market capitalization of..

Doximity, Inc. (DOCS): Investor Outlook with a 33% Upside Potential and Strong Market Position

Doximity, Inc. (DOCS), a prominent player in the healthcare sector, operates as a digital platform tailored for medical professionals in the United States. With a market..

Exelixis, Inc. (EXEL) Stock Analysis: Strong Buy Ratings and Promising Growth in Oncology

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology sector with its keen focus on developing innovative oncology treatments. As a key player in the healthcare..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 23% Upside Potential Amidst Healthcare Sector Dynamics

Fresenius Medical Care AG (NYSE: FMS), a leading player in the healthcare sector specializing in renal care services, offers a compelling investment case for those focused..

Bio-Rad Laboratories, Inc. (BIO): Investor Outlook on Potential Upside and Market Position

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a significant player within the healthcare sector, specifically in the medical devices industry. With a robust market capitalization of..

Waystar Holding Corp. (WAY) Stock Analysis: Navigating a 33% Potential Upside in the Healthcare Information Sector

Waystar Holding Corp. (WAY), a key player in the Healthcare Information Services industry, is capturing investor interest with a compelling potential upside of 33.18%. With a..

Royalty Pharma plc (RPRX) Stock Analysis: Discovering the 14.90% Potential Upside for Investors

Royalty Pharma plc (NASDAQ: RPRX) stands at the intersection of innovation and investment in the biotechnology sector, offering a unique opportunity for investors interested in the..

Novartis AG (NVS) Investor Outlook: Navigating a Healthcare Giant with a 32.62% ROE

As a cornerstone of the healthcare sector, Novartis AG (NYSE: NVS) stands as a formidable player in the pharmaceutical industry. With a market capitalization of $250.21..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with 17.55% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with its promising pipeline of transformative medicines targeting genetic diseases and cancers. With a..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 7.22% Potential Upside Amidst Market Volatility

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, stands out in the healthcare industry with a market capitalization of $10.05 billion. Headquartered in..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 28.42% Potential Upside

Baxter International Inc. (NYSE: BAX) offers a compelling case study for investors interested in the healthcare sector, particularly those focused on medical instruments and supplies. With..

Insulet Corporation (PODD) Investor Outlook: Promising 15.59% Upside Amid Robust Growth

Insulet Corporation (NASDAQ: PODD), a prominent name in the healthcare sector specializing in medical devices, has caught the eye of investors with its innovative insulin delivery..

Search

Funds

December 1, 2025

Search

Funds

December 1, 2025

FTSE 100

Funds